Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Fass

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Antimicrobial Agents and Chemotherapy|November 1, 1993
In vitro activity of Bay y 3118, a new quinoloneR J Fass
Antimicrobial Agents and Chemotherapy|December 1, 1980
Activity of mecillinam alone and in combination with other beta-lactam antibioticsR J Fass
Antimicrobial Agents and Chemotherapy|September 1, 1980
In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophilaR J Fass
Antimicrobial Agents and Chemotherapy|March 1, 1978
Treatment of osteomyelitis and septic arthritis with cefazolinR J Fass
The Journal of Infectious Diseases|June 1, 1984
Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbitsR J Fass
Antimicrobial Agents and Chemotherapy|March 1, 1991
In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciR J Fass
The Journal of Antimicrobial Chemotherapy|November 1, 1986
Treatment of skin and soft tissue infections with oral ciprofloxacinR J Fass
Antimicrobial Agents and Chemotherapy|October 1, 1993
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistanceR J Fass
Antimicrobial Agents and Chemotherapy|February 1, 1981
Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas speciesR J Fass
Antimicrobial Agents and Chemotherapy|October 1, 1983
In vitro activity of ciprofloxacin (Bay o 9867)R J Fass
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|November 1, 1993
In vitro activity of Bay y 3118, a new quinoloneR J Fass
Antimicrobial Agents and Chemotherapy|December 1, 1980
Activity of mecillinam alone and in combination with other beta-lactam antibioticsR J Fass
Antimicrobial Agents and Chemotherapy|September 1, 1980
In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophilaR J Fass
Antimicrobial Agents and Chemotherapy|March 1, 1978
Treatment of osteomyelitis and septic arthritis with cefazolinR J Fass
The Journal of Infectious Diseases|June 1, 1984
Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbitsR J Fass
Antimicrobial Agents and Chemotherapy|March 1, 1991
In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciR J Fass
The Journal of Antimicrobial Chemotherapy|November 1, 1986
Treatment of skin and soft tissue infections with oral ciprofloxacinR J Fass
Antimicrobial Agents and Chemotherapy|October 1, 1993
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistanceR J Fass
Antimicrobial Agents and Chemotherapy|February 1, 1981
Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas speciesR J Fass
Antimicrobial Agents and Chemotherapy|October 1, 1983
In vitro activity of ciprofloxacin (Bay o 9867)R J Fass
Pageof 14